TY  - JOUR

T1  - The effect of basal-bolus therapy varies with baseline 1,5-anhydroglucitol level in people with Type 2 diabetes: a post hoc analysis.

JO  - Diabetic Medicine 

UR  - https://eprints.whiterose.ac.uk/id/eprint/138828

UR  - https://doi.org/10.1111/dme.13693

PY  - 2018/08/07

AU  - Heller S

AU  - Bowering K

AU  - Raskin P

AU  - Liebl A

AU  - Buchholtz K

AU  - Gorst-Rasmussen A

AU  - Pieber TR

ED  - 

DO  - DOI: 10.1111/dme.13693

PB  - Wiley

VL  - 35

IS  - 9

SP  - 1273

EP  - 1278

Y2  - 2025/11/01

ER  -